Company Filing History:
3 out of 27 
1 out of 1 Years Active: 2001-2013
Title: The Innovations of Petrus Johannes Lenting
Introduction
Petrus Johannes Lenting is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of Factor VIII polypeptides. With a total of 4 patents to his name, Lenting's work has had a profound impact on medical science.
Latest Patents
Lenting's latest patents focus on Factor VIII polypeptides that exhibit FVIII:C activity. These polypeptides contain modifications in the A3, C1, and C2 domains of the light chain of Factor VIII. They are characterized by their binding affinity to low-density lipoprotein receptor protein, along with methods for producing these innovative polypeptides.
Career Highlights
Throughout his career, Lenting has worked with prominent organizations such as Stichting Sanquin Bloedvoorziening and Stichting Centraal Laboratorium Van De Bloedtransfusiedienst Van Nederlandse Rode Kruis. His work in these institutions has allowed him to advance research in blood transfusion and related fields.
Collaborations
Lenting has collaborated with esteemed colleagues, including Koenraad Mertens and Jan Aart Van Mourik. These partnerships have further enriched his research and development efforts.
Conclusion
Petrus Johannes Lenting's contributions to biotechnology, particularly in the area of Factor VIII polypeptides, highlight his innovative spirit and dedication to advancing medical science. His work continues to influence the field and improve therapeutic options for patients.